Trince

Biotechnology Research • Ghent, Flemish Region, Belgium • 11-20 Employees

Company overview

Headquarters	Ottergemsesteenweg-Zuid 731, Ghent, Flemish Region 9000, BE
Website	trincebio.com
NAICS	541714
Employees	11-20
Socials

Key Contact at Trince

Kevin Braeckmans

Co-Founder And Cso/Cto

Trince Email Formats

Trince uses 3 email formats. The most common is {first name}.{last name} (e.g., john.doe@trincebio.com), used 57.1% of the time.

Format	Example	Percentage
{first name}.{last name}	john.doe@trincebio.com	57.1%
{first initial}.{last name}	j.doe@trincebio.com	28.6%
{first initial}.{second initial}{last name}	j.odoe@trincebio.com	14.3%

About Trince

Trince is a spin-off company from Ghent University dedicated to advancing cell-based science and therapeutics by facilitating the delivery of molecules into cells, both in vitro and ex vivo. The company's LumiPore transfection platform, which is covered by a portfolio of pending patents, combines laser exposure with photothermal nanoparticles to convert light energy into heat to transiently permeabilize the cellular plasma membrane. It can be used to deliver a wide variety of effector molecules (e.g. nucleic acids or proteins) into virtually any cell type, including hard-to-transfect cells such as immune cells for cell therapies. The technology not only makes it easier to bring genetic material into cells in high-throughput. It also ensures that this is done in a gentle manner, maximizing the therapeutic quality of the final cell product. www.trincebio.com

Trince revenue & valuation

Annual revenue	$1,539,990
Revenue per employee	$86,000
Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues	$5,000,000
Total funding	$4,500,000